3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
13
Prostatic Neoplasms
4
Carcinoma, Hepatocellular
4
Urinary Bladder Neoplasms
3
Urethral Neoplasms
3
Neoplasms
3
Urogenital Neoplasms
2
Ureteral Neoplasms
2
Sarcoma, Ewing
2
Penile Neoplasms
2
Osteosarcoma
2
Neuroendocrine Tumors
2
Melanoma
2
Lung Neoplasms
2
Kidney Neoplasms
2
Clear-cell metastatic renal cell carcinoma
2
Central Nervous System Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Medullary
2
Carcinoma
2
Adrenocortical Carcinoma
2
von Hippel-Lindau Disease
1
Wilms Tumor
1
Urachal adenocarcinoma
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Interventions
Specimen Handling
3
pembrolizumab
2
Magnetic Resonance Spectroscopy
2
Doxorubicin
2
Biopsy
2
talimogene laherparepvec
1
peposertib
1
liposomal doxorubicin
1
fludarabine
1
aldesleukin
1
X-Rays
1
Radiotherapy
1
Radiation
1
Nivolumab
1
Ipilimumab
1
Histamine H2 Antagonists
1
Famotidine
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytoma, Malignant Fibrous
×
cabozantinib
×
30 days
×
Clear all
No trials found.